By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Peter Attia MD#31 – Navdeep Chandel, Ph.D.: metabolism, mitochondria, and metformin in health and disease
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
At a glance
WHAT IT’S REALLY ABOUT
Navdeep Chandel Rethinks Mitochondria as Signaling Hubs, Metformin, and Cancer
- Chandel traces his path from enzyme kinetics to the 1996 finding that cytochrome c release triggers cell death, which showed mitochondria do more than make ATP and led him to study ROS like hydrogen peroxide as physiological signals.
- He argues that because mitochondrial ROS serve beneficial signaling roles in immunity and exercise, failed antioxidant trials and high-dose antioxidant supplements are unsurprising, while the vitamin C needed for gene-regulating enzymes is roughly an orange a day.
- On aging and metformin, he proposes that declining mitochondrial function may be adaptive rather than rate limiting, and that metformin works as a weak complex I inhibitor whose anticancer effect his lab showed depends on complex I using a metformin-resistant yeast enzyme.
- He contends that cancer needs mitochondrial respiration and the TCA cycle, not just glycolysis, and describes early drugs targeting complex I and TCA enzymes, while the hosts discuss the NAD supplement debate, MitoQ, and the importance of cortisol.
- He closes by floating a hypothesis of metabolite toxicity, such as L2-hydroxyglutarate rising when NADH goes up in severe mitochondrial dysfunction, and by giving a hesitant diet answer favoring Mediterranean-style eating with a 15-hour daily fast.
IDEAS WORTH REMEMBERING
5 ideasMitochondria do more than make ATP
Chandel says the 1996 discovery that cytochrome c release from mitochondria triggers apoptosis showed mitochondria control life-and-death decisions, and he now frames them as signaling organelles using cytochrome c, hydrogen peroxide, and metabolites like citrate.
ROS can be beneficial signals, so antioxidants are not simply good
Chandel says mitochondrial hydrogen peroxide helps immune cells function and drives the exercise response, and that antioxidant trials in sepsis and lung cancer failed or did worse; high-dose antioxidants can even blunt exercise benefits.
Falling mitochondrial function with age may be adaptive, not causal
Chandel notes that mitochondrial capacity declines with age but a 50% reduction in function shows no pathology in knockout work, so he argues it may not be rate limiting and that correlation does not show it drives aging.
Metformin's effects likely run through weak complex I inhibition
Chandel's lab showed that replacing complex I with a metformin-resistant yeast enzyme removed metformin's tumor-shrinking effect, and he thinks mild inhibition turns on adaptive stress responses and lowers inflammation, though the diabetes and inflammation mechanisms are less settled.
Cancer depends on mitochondria, not only glycolysis
Chandel's genetic knockout of the respiratory chain in mouse lung tumors produced tiny tumors, and he points out that nucleotides need ribose from glucose plus nitrogen and amino acids from mitochondria, so both are necessary but neither is sufficient.
WORDS WORTH SAVING
5 quotesSo if it's in the mitochondria, it helps you generate ATP. If it's out, it kills you.
— Navdeep Chandel
It's like a henhouse next to where the foxes live.
— Navdeep Chandel
Yes, mitochondrial function goes down, so that's a correlation with aging. That doesn't mean that decrease in mitochondrial function causes aging or drives aging. It's just a correlation. It could be adaptive or maladaptive.
— Navdeep Chandel
The Venn diagram where they all overlap is inflammation.
— Navdeep Chandel
There are no problems worth solving that are easy.
— Peter Attia
High quality AI-generated summary created from speaker-labeled transcript.
